Warning! GuruFocus detected
2 Severe warning signs
with CBO.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Imunon Inc
NAICS : 325412
SIC : 2834
ISIN : US15117N5032
Description
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 5.16 | |||||
| Equity-to-Asset | 0.44 | |||||
| Debt-to-Equity | 0.27 | |||||
| Debt-to-EBITDA | -0.06 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 26 | |||||
| 3-Year EPS without NRI Growth Rate | 24.2 | |||||
| 3-Year FCF Growth Rate | 18.6 | |||||
| 3-Year Book Growth Rate | -68.8 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 25.66 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 35.87 | |||||
| 9-Day RSI | 39.16 | |||||
| 14-Day RSI | 41.85 | |||||
| 3-1 Month Momentum % | -10.86 | |||||
| 6-1 Month Momentum % | -14.75 | |||||
| 12-1 Month Momentum % | -45.07 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.67 | |||||
| Quick Ratio | 1.67 | |||||
| Cash Ratio | 1.23 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -36 | |||||
| Shareholder Yield % | -57.49 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -244.58 | |||||
| ROA % | -132.92 | |||||
| ROIC % | -684.08 | |||||
| 3-Year ROIIC % | -2.69 | |||||
| ROC (Joel Greenblatt) % | -932.03 | |||||
| ROCE % | -218.91 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2.97 | |||||
| Price-to-Tangible-Book | 3.04 | |||||
| EV-to-EBIT | -0.43 | |||||
| EV-to-Forward-EBIT | -0.28 | |||||
| EV-to-EBITDA | -0.45 | |||||
| EV-to-FCF | -0.42 | |||||
| Price-to-GF-Value | 2.03 | |||||
| Price-to-Net-Current-Asset-Value | 5.21 | |||||
| Price-to-Net-Cash | 24.33 | |||||
| Earnings Yield (Greenblatt) % | -232.56 | |||||
| FCF Yield % | -148.47 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Imunon Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -1.478 | ||
| Beta | 1.41 | ||
| 3-Year Sharpe Ratio | -0.15 | ||
| 3-Year Sortino Ratio | -0.3 | ||
| Volatility % | 85.97 | ||
| 14-Day RSI | 41.85 | ||
| 14-Day ATR (€) | 0.046549 | ||
| 20-Day SMA (€) | 0.856 | ||
| 12-1 Month Momentum % | -45.07 | ||
| 52-Week Range (€) | 0.58 - 3.7 | ||
| Shares Outstanding (Mil) | 14.62 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Imunon Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Imunon Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Imunon Inc Frequently Asked Questions
What is Imunon Inc(FRA:CBO)'s stock price today?
The current price of FRA:CBO is €0.73. The 52 week high of FRA:CBO is €3.70 and 52 week low is €0.58.
When is next earnings date of Imunon Inc(FRA:CBO)?
The next earnings date of Imunon Inc(FRA:CBO) is 2025-05-13 Est..
Does Imunon Inc(FRA:CBO) pay dividends? If so, how much?
Imunon Inc(FRA:CBO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers